Cargando…
Amyloid-β Plaques in Clinical Alzheimer’s Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity
Alzheimer’s disease (AD) is a neurodegenerative disorder with clinical manifestations of progressive memory decline and loss of executive function and language. AD affects an estimated 5.3 million Americans alone and is the most common form of age-related dementia with a rapidly growing prevalence a...
Autores principales: | Wildburger, Norelle C., Gyngard, Frank, Guillermier, Christelle, Patterson, Bruce W., Elbert, Donald, Mawuenyega, Kwasi G., Schneider, Theresa, Green, Karen, Roth, Robyn, Schmidt, Robert E., Cairns, Nigel J., Benzinger, Tammie L. S., Steinhauser, Matthew L., Bateman, Randall J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874304/ https://www.ncbi.nlm.nih.gov/pubmed/29623063 http://dx.doi.org/10.3389/fneur.2018.00169 |
Ejemplares similares
-
Coupling APEX labeling to imaging mass spectrometry of single organelles reveals heterogeneity in lysosomal protein turnover
por: Narendra, Derek P., et al.
Publicado: (2019) -
Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways
por: Elbert, Donald L., et al.
Publicado: (2022) -
Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
por: Esparza, Thomas J., et al.
Publicado: (2016) -
Isotopic Tracers
Publicado: (1955) -
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
por: Brody, David L., et al.
Publicado: (2017)